These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12734764)

  • 1. Transient restless legs-like syndrome as a complication of opiate withrawal.
    Scherbaum N; Stüper B; Bonnet U; Gastpar M
    Pharmacopsychiatry; 2003; 36(2):70-2. PubMed ID: 12734764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of idiopathic and uremic restless legs syndrome].
    Trenkwalder C; Stiasny K; Oertel WH
    Nervenarzt; 1996 Apr; 67(4):265-76. PubMed ID: 8684504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Six months treatment of restless legs syndrome with levodopa/benserazide in domiciliary practice].
    Mühlau G
    MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):87-93. PubMed ID: 15662897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid.
    Eisensehr I; Ehrenberg BL; Rogge Solti S; Noachtar S
    J Neurol; 2004 May; 251(5):579-83. PubMed ID: 15164191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Restless legs, restless nights: therapeutic options in RLS].
    Kassubek J; Unrath A
    MMW Fortschr Med; 2009 Mar; 151(13):65-7, 69. PubMed ID: 19504823
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of the restless leg syndrome with or without periodic leg movements in sleep.
    Montplaisir J; Lapierre O; Warnes H; Pelletier G
    Sleep; 1992 Oct; 15(5):391-5. PubMed ID: 1360697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [L-dopa, dopamine agonists, opiates... what calms down restless legs].
    Wepner U
    MMW Fortschr Med; 2005 Feb; 147(8):6, 8. PubMed ID: 18437857
    [No Abstract]   [Full Text] [Related]  

  • 8. One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome?
    Trenkwalder C; Collado Seidel V; Kazenwadel J; Wetter TC; Oertel W; Selzer R; Kohnen R
    Mov Disord; 2003 Oct; 18(10):1184-9. PubMed ID: 14534925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness.
    Kallweit U; Khatami R; Pizza F; Mathis J; Bassetti CL
    Clin Neuropharmacol; 2010; 33(6):276-8. PubMed ID: 21060282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restless legs: recent advances in basic research and therapy].
    Sieb JP
    Med Monatsschr Pharm; 2010 Apr; 33(4):133-9. PubMed ID: 20429403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of restless leg syndrome with pergolide--an open clinical trial.
    Winkelmann J; Wetter TC; Stiasny K; Oertel WH; Trenkwalder C
    Mov Disord; 1998 May; 13(3):566-9. PubMed ID: 9613756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restless legs syndrome: therapeutic possibilities in the medical practice].
    Bachmann CG; Trenkwalder C
    MMW Fortschr Med; 2005 May; 147 Spec No 2():44-7. PubMed ID: 15968872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging drugs for restless legs syndrome.
    Fulda S; Wetter TC
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):537-52. PubMed ID: 16083328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the "L-DOPA test" for diagnosis of restless legs syndrome.
    Stiasny-Kolster K; Kohnen R; Möller JC; Trenkwalder C; Oertel WH
    Mov Disord; 2006 Sep; 21(9):1333-9. PubMed ID: 16705685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine dysregulation syndrome in a patient with restless legs syndrome.
    Leu-Semenescu S; Karroum E; Brion A; Konofal E; Arnulf I
    Sleep Med; 2009 Apr; 10(4):494-6. PubMed ID: 19410183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
    Enomoto M; Inoue Y; Namba K; Munezawa T; Matsuura M
    Mov Disord; 2008 Apr; 23(6):811-6; quiz 926. PubMed ID: 18074382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic augmentation of restless legs syndrome.
    García-Borreguero D; Williams AM
    Sleep Med Rev; 2010 Oct; 14(5):339-46. PubMed ID: 20219397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.